- Home
- SERV vs NKTR Comparison
SERV vs NKTR Comparison
Compare SERV & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SERV | NKTR |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 913.2M | 2.1B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | SERV | NKTR |
|---|---|---|
| Price | $9.20 | $73.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $18.80 | ★ $129.83 |
| AVG Volume (30 Days) | ★ 3.1M | 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $307,711,000.00 |
| Revenue This Year | $872.80 | N/A |
| Revenue Next Year | $199.55 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 86.00 |
| 52 Week Low | $4.66 | $0.43 |
| 52 Week High | $18.64 | $75.67 |
Technical Indicators
Market Signals| Indicator | SERV | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 63.41 |
| Support Level | $8.02 | $52.99 |
| Resistance Level | $11.00 | $75.44 |
| Average True Range (ATR) | 0.67 | 4.13 |
| MACD | 0.06 | -0.82 |
| Stochastic Oscillator | 6.96 | 65.76 |
Price Performance
Historical ComparisonAbout SERV Serve Robotics Inc.
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.